|Looking beyond the hype: Applied AI and machine learning in translational medicine|
TS Toh, F Dondelinger, D Wang
EBioMedicine 47, 607-615, 2019
|Defining subpopulations of differential drug response to reveal novel target populations|
N Keshava, TS Toh, H Yuan, B Yang, MP Menden, D Wang
npj Systems Biology and Applications 5 (1), 1-11, 2019
|A statistical framework for assessing pharmacological responses and biomarkers using uncertainty estimates|
D Wang, J Hensman, G Kutkaite, TS Toh, A Galhoz, JR Dry, ...
Elife 9, e60352, 2020
|Limited-Stage Small Cell Lung Cancer: Outcomes Associated with Prophylactic Cranial Irradiation Over a 20-year Period at the Princess Margaret Cancer Centre|
M Yan, TS Toh, PE Lindsay, J Weiss, K Hueniken, C Yeung, V Sugumar, ...
Clinical and Translational Radiation Oncology, 2021
|A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted Analysis|
M Yan, S Sigurdson, N Greifer, TAC Kennedy, TS Toh, PE Lindsay, ...
Cancers 13 (12), 2895, 2021
|131: Limited-Stage Small Cell Lung Cancer: Outcomes Associated with Prophylactic Cranial Irradiation Over A 20-Year Period At A Single Institution|
M Yan, TS Toh, P Lindsay, J Weiss, K Hueniken, V Sugumar, C Yeung, ...
Radiotherapy and Oncology 150, S57, 2020
|Outcomes of IMRT/VMAT vs 2D/3D-conformal thoracic radiation in limited stage small-cell lung cancer|
TS Toh, A Bang, D Pinto, K Hueniken, C Brown, W Xu, G Liu, B Lok
Radiotherapy and Oncology 133, S399-S400, 2019